![](https://www.diabetesnews.com/wp-content/uploads/2017/08/iStock_000012888324_Smallliver-150x150.jpg)
Nonalcoholic fatty liver disease (NAFLD) often occurs in patients with type 2 diabetes. A recent study showed that the diabetes medications liraglutide and sitagliptin, in combination with metformin, can improve intrahepatic lipid and therefore benefit NAFLD. Read more